Who has invested in Colossal Biosciences?

TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins are named among the investors backing Colossal Biosciences.

Colossal Biosciences Funding: $615M Raised, Series C (2026)

Colossal Biosciences funding overview

Colossal Biosciences is a Biotech company based in Dallas, Texas. Colossal Biosciences has raised $615M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in March 2026. The round record for Colossal Biosciences runs through 2026; nothing later has been disclosed. Investors on record include TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins and 7 others. 13 distinct backers are named across the disclosed rounds.

Colossal Biosciences at a glance

Total raised: $615M
Latest round: Series C
Latest round date: March 2026
Industry: Biotech
Headquarters: Dallas, Texas
Notable investors: TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins, Winklevoss Capital Management, Paris Hilton

Frequently asked about Colossal Biosciences funding

How much has Colossal Biosciences raised?: Colossal Biosciences has raised $615M in total disclosed funding across the rounds on record.
Who has invested in Colossal Biosciences?: TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins are named among the investors backing Colossal Biosciences.
What was the latest Colossal Biosciences funding round?: The most recent disclosed round is a Series C, announced in March 2026.
Where is Colossal Biosciences based?: Colossal Biosciences is based in Dallas, Texas.
What sector does Colossal Biosciences operate in?: Colossal Biosciences is tracked under Biotech from Dallas, Texas, with $615M in disclosed funding.
When did Colossal Biosciences last raise?: The last disclosed Colossal Biosciences round closed in March 2026 at Series C.

Colossal Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Dallas below to benchmark round size and investor mix.

Colossal Biosciences Funding: $615M Raised, Series C (2026)

Colossal Biosciences funding overview

Colossal Biosciences at a glance

Frequently asked about Colossal Biosciences funding

Colossal Biosciences founders (1)

Companies related to Colossal Biosciences (37)

Browse related funding lists (5)